Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 5, 1996, Pages 1023-1032

  Solem, L E ^a,b   Heller, L J ^b   Wallace, K B ^b   Wallace, Kendall B ^c  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA DULUTH   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adriamycin; Calcium; Cardiac; Doxorubicin; Mitochondria; Mitochondrial permeability transition

Indexed keywords

CALCIUM; CYCLOSPORIN A; DOXORUBICIN; RUTHENIUM RED;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM BALANCE; CALCIUM TRANSPORT; CARDIOMYOPATHY; CELL DAMAGE; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; MALE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029941234     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0095     Document Type: Article

References (36)

1. ALLEN A, 1992. The cardiotoxicity of chemotherapeutic drugs. Seminars in Oncology 19: 529-542.
2. 2+ transport in rat heart mitochondria. Toxical Lett 3: 29-34.
3. BRADFORD MM, 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. BRISTOW MR, MASON JW, BILLINGHAM ME, 1978. Doxorubicin cardiomyopathy: Evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med 88: 168-175.
5. 2+: An alternate mechanism for cardiotoxicity of doxorubicin. Toxicol Appl Pharmacol 107: 117-128.
6. 2+ increase by doxorubicin in cardiac myocytes. Biochem J 281: 871-878.
7. CINI NERI G, NERI B, BANDINELLI M, DEL TACCA M, DANESI R, 1991. Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat. Oncology 48: 327-333.
8. CORTES EP, LUTMAN G, WANKA J et al., 1975. Adriamycin (NSC-123127) cardiotoxicity. A clinicopathologic correlation. Cancer Treat Rep 6: 215-225.
9. DAVIES KJA, DOROSHOW JH, 1986. Redox cycling of anthracyclines by cardiac mitochondria. J Biol Chem 261: 3060-3067.
10. 2+ as a second messenger with mitochondria of the heart and other tissues. Annu Rev Physiol 52: 451-466.
11. DOROSHOW JH, 1983. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res 43: 460-472.
12. EARM YE, HO W, SO I, 1994. Effects of Adriamycin on ionic currents in single cardiac myocytes of the rabbit. J Mol Cell Cardiol 26: 163-172.
13. EMAUS RK, GRUNWALD R, LEMASTERS JJ, 1986. Rhodamine 123 as a probe of transmembrane potential isolated rat liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta 850: 436-448.
14. FORD DA, ROVETTO MJ, 1987. Rat cardiac myocyte adenosine transport and metabolism. Am J Physiol 252: H54-H63.
15. GEISBUHLER TP, JOHNSON DA, ROVETTO MJ, 1987. Cardiac myocyte guanosine transport and metabolism. Am J Physiol 253: C645-C651.
16. GUNTER TE PFEIFFER DR, 1990. Mechanisms by which mitochondria transport calcium. Am J Physiol 258: C755-C786.
17. GUNTER TE, GUNTER KK, SHEU SS, GAVIN CE, 1994. Mitochondrial calcium transport: physiological and pathological relevance. Am J Physiol 267: C313-C339.
18. HARMAN AW, MAXWELL MJ, 1995. An evaluation of the role of calcium in cell injury. Annu Rev Pharmacol Toxicol 35: 129-144.
19. HERMAN EH, FERRANS VJ, MYERS CE, VAN VLEET JF, 1985. Comparison of the effectiveness of (±)-1,2-Bis(3,5-dioxopiperazmyl-1-yl)propane (IRCF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles. Cancer Res 45: 276-281.
20. LEFRAK EA, PITHA J, ROSENHEIM S, GOTTLIEB JA, 1973. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32: 302-314.
21. MAISCH B, GREGOR O, ZEUSS M, KOCHSIEK K, 1985. Acute effect of calcium channel blockers on adriamycin exposed isolated adult cardiomyocytes. Basic Res Cardiol 80: 626-635.
22. METTLER FP, YOUNG DM, WARD JJ, 1977. Adriamycin-induced cardiotoxicity (Cardiomyopathy and congestive heart failure) in rats. Cancer Res 37: 2705-2713.
23. MIMNAUGH EG, TRUSH MA, BHATNAGAR M, GRAM TE, 1985. Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin. Biochem Pharmacol 34: 847-856.
24. MONTI E PICCININI F, VILLANI F, FAVALLI L, 1986. Myocardial contractility and heart pharmacokinetics of adriamycin following a single administration in rat. Cancer Chemother Pharmacol 18: 289-291.
25. OLSON RD, MUSHLIN PS, 1990. Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses. FASEB 74: 3076-3086.
26. PETRONILLI V, COSTANTINI P, SCORRANO L, COLONNA R, PASSAMONTI S, BERNARDI P, 1994. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. J Biol Chem 269: 16638-16642.
27. POWIS G, 1989. Free radical formation by antitumor quinones. Free Radical Biol Med 6: 63-101.
28. PRAGA C, BERETTA G, VIGO PL, 1979. Adriamycin cardiotoxicity: A survey of 1273 patients. Cancer Treat Rep 63: 827-834.
29. REVIS NW, MARUSIC N, 1979. Effects of doxorubicin and its aglycone metabolite on calcium sequestration by rabbit heart, liver, and kidney mitochondria. Life Sci 25: 1055-1064.
30. 2+ homeostasis, cell death, proliferation, and differentiation. Chem-biol Interactions 77: 1-23.
31. SCARPA A, 1979. Measurement of cation transport with metallochromic indicators. In: S. Fleischer and L. Packer (Eds), Methods of Enzymology Vol. 56, Academic Press, New York: 301-352.
32. SERAYDARIN MW, ARTAZA L, GOODMAN MF, 1977. Adriamycin: effect on mammalian cardiac cell in culture I. Cell population and energy metabolism. J Mol Cell Cardiol 9: 375-382.
33. SINGAL PK, DEALLY CMR, WEINBERG LE, 19 8 7. Subcellular effects of adriamycin in the heart: a concise review. 7 Mol Cell Cardiol 19: 817-828.
34. 2+ from rat heart mitochondria: induction by adriamycin aglycone. Biochem Pharmacol 37: 803-812.
35. SOLEM LE, WALLACE KB, 1993. Selective activation of the sodium-independent, cyclosporine A-sensitive calcium pore of cardiac mitochondria by doxorubicin. Toxicol Appl Pharmacol 121: 50-57.
36. SOLEM LE, HENRY TR, WALLACE KB, 1994. Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol Appl Pharmacol 129: 214-222.